Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

NCT04138719 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

520

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Triple-negative Breast Cancer
Nab-paclitaxel

Interventions

DRUG: Nab-paclitaxel + Carboplatin
DRUG: Nab-paclitaxel + Epirubicin

Sponsor

Hebei Medical University Fourth Hospital

Collaborators

[object Object]
[object Object]